Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000017283-00-000124
Filing Date
2000-02-11
Accepted
2000-02-11 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G 6317
  Complete submission text file 0000017283-00-000124.txt   8190
Mailing Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE ST 55TH FLOOR LOS ANGELES CA 90071 2134869200
CAPITAL RESEARCH & MANAGEMENT CO (Filed by) CIK: 0000017283 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 0000

Mailing Address 505 PENOBSCOT DR REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR REDWOOD CITY CA 94063 6503969500
GENELABS TECHNOLOGIES INC /CA (Subject) CIK: 0000874443 (see all company filings)

EIN.: 943010150 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42078 | Film No.: 533661
SIC: 2834 Pharmaceutical Preparations